Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia | MicrobiomeTrials← Back to trialsNCT01660308
Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
UNKNOWNOBSERVATIONAL
Trial Details
Start: 2011-06Est. Completion: 2016-08
Enrollment target: 40 participants Locations- National Taiwan University Hospital, Taipei, Taiwan, Taiwan
Other microbiome trials you might be interested in
HypophosphatemiaKidney Transplantation
The primary goal is to determine if Dipyridamole can improve serum phosphate levels and reduce the need for phosphate su…
Stanford, United StatesEst. completion May 2027
SepsisAcute Kidney InjuryContinuous Renal Replacement Therapy (CRRT)
This multicenter, randomized, open-label, active-controlled, parallel-group trial will evaluate the efficacy and safety …
Multiple LocationsEst. completion Jun 10, 2028
HypophosphatemiaRicketsHypercalciuriaXLHHHRH
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/…
New Haven, United StatesEst. completion Apr 2028